Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2150164726;64727;64728 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
N2AB1986059803;59804;59805 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
N2A1893357022;57023;57024 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
N2B1243637531;37532;37533 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
Novex-11256137906;37907;37908 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
Novex-21262838107;38108;38109 chr2:178585243;178585242;178585241chr2:179449970;179449969;179449968
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-124
  • Domain position: 33
  • Structural Position: 49
  • Q(SASA): 0.2553
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/I rs1251141163 0.416 0.938 N 0.689 0.199 0.335414705075 gnomAD-2.1.1 4.03E-06 None None None None N None 6.47E-05 0 None 0 0 None 0 None 0 0 0
K/I rs1251141163 0.416 0.938 N 0.689 0.199 0.335414705075 gnomAD-4.0.0 1.59228E-06 None None None None N None 5.66251E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.3866 ambiguous 0.3715 ambiguous -0.689 Destabilizing 0.919 D 0.589 neutral None None None None N
K/C 0.4827 ambiguous 0.4806 ambiguous -1.087 Destabilizing 0.999 D 0.738 prob.delet. None None None None N
K/D 0.7686 likely_pathogenic 0.7377 pathogenic -0.96 Destabilizing 0.996 D 0.714 prob.delet. None None None None N
K/E 0.2106 likely_benign 0.1962 benign -0.824 Destabilizing 0.946 D 0.521 neutral N 0.465366675 None None N
K/F 0.5423 ambiguous 0.536 ambiguous -0.427 Destabilizing 0.976 D 0.753 deleterious None None None None N
K/G 0.5416 ambiguous 0.52 ambiguous -1.068 Destabilizing 0.988 D 0.675 neutral None None None None N
K/H 0.2435 likely_benign 0.2446 benign -1.457 Destabilizing 0.999 D 0.691 prob.neutral None None None None N
K/I 0.2057 likely_benign 0.2001 benign 0.305 Stabilizing 0.938 D 0.689 prob.neutral N 0.464673242 None None N
K/L 0.1971 likely_benign 0.1975 benign 0.305 Stabilizing 0.034 N 0.453 neutral None None None None N
K/M 0.1167 likely_benign 0.1126 benign 0.154 Stabilizing 0.702 D 0.472 neutral None None None None N
K/N 0.4616 ambiguous 0.4312 ambiguous -0.958 Destabilizing 0.984 D 0.606 neutral N 0.498305813 None None N
K/P 0.9834 likely_pathogenic 0.9819 pathogenic 0.003 Stabilizing 0.996 D 0.714 prob.delet. None None None None N
K/Q 0.0974 likely_benign 0.1015 benign -1.04 Destabilizing 0.984 D 0.595 neutral N 0.434390407 None None N
K/R 0.0754 likely_benign 0.0776 benign -0.818 Destabilizing 0.946 D 0.515 neutral N 0.463673164 None None N
K/S 0.4188 ambiguous 0.3899 ambiguous -1.53 Destabilizing 0.959 D 0.527 neutral None None None None N
K/T 0.1548 likely_benign 0.1504 benign -1.186 Destabilizing 0.896 D 0.634 neutral N 0.439102793 None None N
K/V 0.2087 likely_benign 0.203 benign 0.003 Stabilizing 0.851 D 0.633 neutral None None None None N
K/W 0.5617 ambiguous 0.5686 pathogenic -0.374 Destabilizing 0.999 D 0.729 prob.delet. None None None None N
K/Y 0.4454 ambiguous 0.4381 ambiguous 0.009 Stabilizing 0.988 D 0.733 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.